Production (Stage)
Sagimet Biosciences Inc.
SGMT
$3.55
$0.051.43%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 144.57M | 151.25M | 152.49M | 166.37M | 193.71M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 615.00K | 1.06M | 4.30M | 248.00K | 678.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 888.00K | 463.00K | 407.00K | 130.00K | 108.00K |
| Total Current Assets | 146.07M | 152.77M | 157.19M | 166.75M | 194.49M |
|
|
|||||
| Total Current Assets | 146.07M | 152.77M | 157.19M | 166.75M | 194.49M |
| Net Property, Plant & Equipment | 38.00K | 77.00K | 114.00K | 151.00K | 37.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 62.00K | -- | -- | -- | -- |
| Total Assets | 146.17M | 160.26M | 174.78M | 189.02M | 194.53M |
|
|
|||||
| Total Accounts Payable | 3.22M | 1.43M | 1.15M | 1.99M | 531.00K |
| Total Accrued Expenses | 3.86M | 2.95M | 2.81M | 3.57M | 3.95M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 39.00K | 78.00K | 116.00K | 153.00K | 26.00K |
| Total Finance Division Other Current Liabilities | 63.00K | 5.00K | 11.00K | 10.00K | -- |
| Total Other Current Liabilities | 63.00K | 5.00K | 11.00K | 10.00K | -- |
| Total Current Liabilities | 7.18M | 4.45M | 4.09M | 5.73M | 4.51M |
|
|
|||||
| Total Current Liabilities | 7.18M | 4.45M | 4.09M | 5.73M | 4.51M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 7.18M | 4.45M | 4.09M | 5.73M | 4.51M |
|
|
|||||
| Common Stock & APIC | 452.36M | 450.89M | 449.35M | 447.81M | 446.38M |
| Retained Earnings | -313.49M | -295.31M | -279.11M | -264.49M | -256.37M |
| Treasury Stock & Other | 121.00K | 230.00K | 441.00K | -23.00K | 7.00K |
| Total Common Equity | 138.99M | 155.81M | 170.68M | 183.29M | 190.02M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 138.99M | 155.81M | 170.68M | 183.29M | 190.02M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 138.99M | 155.81M | 170.68M | 183.29M | 190.02M |
|
|
|||||